Technical Analysis for CVM - Cel-Sci Corporation

Grade Last Price % Change Price Change
grade A 11.62 -4.05% -0.49
CVM closed down 4.05 percent on Friday, March 27, 2020, on 39 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Up
Historical CVM trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Narrow Range Bar Range Contraction -4.05%
NR7 Range Contraction -4.05%
NR7-2 Range Contraction -4.05%
Wide Bands Range Expansion -4.05%
20 DMA Support Bullish -1.19%
Narrow Range Bar Range Contraction -1.19%
NR7 Range Contraction -1.19%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

CEL-SCI Corporation engages in the research and development of drugs and vaccines. The company's principal product, Multikine, is under Phase III clinical trial for the treatment of head and neck cancer. The Multikine is an immunotherapeutic agent consisting of a mixture of cytokines that produce an anti-tumor immune response. It also develops Ligand Epitope Antigen Presentation System (LEAPs), a heteroconjugate technology that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune, allergies, transplantation rejection, and cancer. The company, through its LEAPS technology, develops a peptide treatment for H1N1 hospitalized patients; and CEL-2000, a rheumatoid arthritis vaccine. CEL-SCI Corporation was founded in 1983 and is based in Vienna, Virginia.
Medicine Cancer Medical Specialties Immunology Immunotherapy Immune System Rheumatoid Arthritis Vaccination Autoimmunity Transplantation Head And Neck Cancer Vaccine Allergies Treatment Of Head And Neck Cancer

Is CVM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 17.8
52 Week Low 3.695
Average Volume 1,160,106
200-Day Moving Average 9.11
50-Day Moving Average 12.91
20-Day Moving Average 11.55
10-Day Moving Average 11.46
Average True Range 1.65
ADX 15.71
+DI 22.63
-DI 21.22
Chandelier Exit (Long, 3 ATRs ) 10.88
Chandelier Exit (Short, 3 ATRs ) 13.06
Upper Bollinger Band 14.12
Lower Bollinger Band 8.97
Percent B (%b) 0.51
BandWidth 44.57
MACD Line -0.27
MACD Signal Line -0.41
MACD Histogram 0.1458
Fundamentals Value
Market Cap 108.45 Million
Num Shares 9.33 Million
EPS -1.54
Price-to-Earnings (P/E) Ratio -7.55
Price-to-Sales 102.40
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 12.61
Resistance 3 (R3) 12.70 12.45 12.45
Resistance 2 (R2) 12.45 12.20 12.41 12.39
Resistance 1 (R1) 12.04 12.05 11.92 11.95 12.33
Pivot Point 11.79 11.79 11.73 11.75 11.79
Support 1 (S1) 11.38 11.54 11.26 11.29 10.91
Support 2 (S2) 11.13 11.39 11.09 10.85
Support 3 (S3) 10.72 11.13 10.80
Support 4 (S4) 10.63